Study of genetic heart muscle disease and its outlook
Part of Heart & circulation clinical trials.
This study looks at people with a genetic heart muscle condition called cardiomyopathy, which can cause irregular heartbeats. By studying your condition, doctors hope to better understand how it develops, how to predict its course, and how to improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older.
- You have a probable or confirmed diagnosis of cardiomyopathy (a disease of the heart muscle).
- You carry a specific genetic change (mutation) that is known to cause cardiomyopathy.
- You are able to understand and agree to take part in the research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at people with cardiomyopathy to understand which patients are most in need of a heart transplant. By joining, you will help doctors learn more about critical cases and improve care for heart muscle disease.
This trial evaluates early prevention and treatment strategies for arrhythmogenic cardiomyopathy (ACM), a heart condition that can cause abnormal heart rhythms. It aims to improve care by using advanced tests like heart imaging and genetic sequencing to guide treatment.
This study looks at genetic causes of inherited heart (cardiovascular) and muscle/nerve (neuromuscular) conditions. You may be asked about your family history and possibly genetic samples to help connect symptoms to specific genetic changes.
This study looks at genetic (DNA) changes that may cause cardiomyopathy, a disease where the heart muscle is weakened. It may help families understand possible causes and inform future care.
This study looks at the genes of people whose heart muscle becomes weak due to a fast or irregular heartbeat (atrial fibrillation or flutter). The goal is to better understand why this happens in some people and not others.
This study is a registry that collects information from people with arrhythmogenic cardiomyopathy who have an ICD. The goal is to learn more about the condition, its heart rhythm complications, and how the ICD works, which may help improve future care.
Hear when a new Arrhythmogenic Cardiomyopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.